Evidence map›Paper›PMID 38633428›Full record

ArticleChina CDC weekly2024

An Outbreak of Serogroup Y Meningococcal Meningitis in a Private Secondary Vocational School - Guangzhou City, Guangdong Province, China, 2023.

Xiang Zeng, Qing He, Yilan Li, Yong Zhou, Xiaoping Shao, Pei Hu, Jian Liang, Yudan Song, Chao Ma, Lijie Zhang and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. The First Case of Serogroup YChina CDC weekly · 2024
    Article
  3. Immunity Dynamics ofVaccines · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xiang ZengChinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Qing HeGuangzhou Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Yilan LiGuangzhou Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Yong ZhouGuangzhou Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Xiaoping ShaoGuangdong Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Pei HuGuangdong Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Jian LiangGuangdong Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Yudan SongDepartment of the National Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing, China.
Chao MaDepartment of the National Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing, China.
Lijie ZhangChinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Limei SunGuangdong Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Lei LuoGuangzhou Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
Guangzhou Center for Disease Control and Prevention · CNChinese Center For Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: The inclusion of meningococcal vaccines in the National Immunization Program (NIP) over several years has significantly reduced the incidence of meningococcal meningitis in China to historic lows. Worldwide, there has been a diversification of meningococcal serogroups, leading to a shift in dominant serogroups in China from serogroup A to serogroups C and B, accompanied by a rise in reports of serogroups Y and W. What is added by this report?: An outbreak of serogroup Y What are the implications for public health practice?: This outbreak underscores the critical need to enhance surveillance of meningococcal serogroups and population carrier, and advocate for vaccination with MenY-containing vaccines.

Indexed as

Meningococcal meningitisNeisseria meningitidisOutbreakSerogroup Y

Identifiers

PMID38633428
PMCPMC11018515
OpenAlexW4393154567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.